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Reducing tobacco product appeal and use through product regulation:
•	 Tobacco product regulation is a powerful tool that can help to decrease the appeal and subsequent use 
of tobacco products.
•	 Tobacco product regulation should be part of a comprehensive tobacco control programme.
•	 Tobacco product regulation includes measurement of contents and emissions of tobacco products, their 
regulation and disclosure to regulatory authorities and the public.
•	 Examples	include	bans	or	the	restriction	of	flavours,	bans	on	product	categories	e.g.	smokeless	tobacco	
or electronic nicotine delivery systems (ENDS), or disclosure of the contents of tobacco and related 
products, such as nicotine and sugars. 
•	 Testing methods for product regulation should have zero industry involvement (industry-independent).
•	 The development and validation of testing methods is crucial to regulate tobacco products, including 
data	verification.
•	 Tobacco product regulation need not be expensive as regulators can charge tobacco manufacturers for 
costs involved in testing products by independent labs.
 
Why is tobacco product regulation important?
Despite their devastating health effects, tobacco and 
related products are designed to appeal to young 
people,	are	addictive,	openly	marketed	and	either	
under-regulated or not regulated.1 Given the number 
of people that die every year from tobacco-related 
illness, these products should be regulated. Tobacco-
product regulation, which forms part of a compre-
hensive tobacco control programme, should thus 
be actively pursued. To achieve this, countries can 
require	tobacco	manufacturers	to	make	their	prod-
ucts less attractive, toxic and addictive,1 especially to 
young people, by amending existing tobacco-control 
laws to include tobacco product-regulation provisions. 
Regulatory measures, such as setting product stan-
dards or banning product features or categories, aim 
to reduce tobacco use prevalence and tobacco-related 
harm. Examples include restriction and/or banning of 
flavours	and	sugars	in	tobacco	products,	restriction	
on	filter	features,	such	as	filter	ventilation2 and setting 
limits on the levels of emissions generated.2,3 
It	must	be	noted	that	no	machine	smoking	regimen	
can	represent	all	human	smoking	behaviour;	machine	
smoking	testing	is	useful	for	characterizing	cigarette	
emissions for design and regulatory purposes, but 
communication	of	machine	measurements	to	smok-
ers can result in misunderstanding about differences 
in	exposure	and	risk	between	brands;	data	on	smoke	
emissions from machine measurements may be used 
as inputs for product hazard assessment but they are 
not intended to be nor are they valid as measures of 
human	exposure	or	risks	and	representing	differ-
ences in machine measurements as differences in 
exposure	or	risk	is	a	misuse	of	testing	with	WHO	
TobLabNet standards.
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What	is	the	significance	of	these	methods	
for tobacco product regulation?
The importance of tobacco product regulation is 
reflected	in	articles	9	and	10	of	the	WHO	Framework	
convention	on	Tobacco	control	 (WHO	FcTc).4 
article	9	sets	out	the	obligation	of	Parties	in	regulat-
ing the contents and emissions of tobacco products. 
article	10,	on	the	other	hand,	involves	the	disclosure	
of such information by tobacco manufacturers to 
responsible national authorities for tobacco-prod-
uct regulation, for regulators to extract relevant 
information in a meaningful way to inform the pub-
lic about the toxic constituents of tobacco products 
and the emissions that they may produce. The asso-
ciated guidelines for both Articles recommend that 
Parties	prohibit	or	restrict	ingredients	that	increase	
palatability	of	tobacco	products	(e.g.	flavourings)	and	
also set out the requirements for independent testing 
and measurement of the contents and emissions of 
tobacco products.5 
How	can	measuring	tobacco	product	
contents and emissions advance tobacco 
product regulation?
Regulators can measure and monitor levels of com-
pounds in tobacco products or their emissions 
to understand the type and amount of chemical 
substances to which consumers are exposed. This 
may help formulate policies to reduce the toxicity, 
attractiveness and addictiveness of tobacco and 
have the potential to contribute to reduced tobacco 
use.	Following	implementation	of	regulatory	policies,	
these compounds can be measured for compliance 
purposes	and	remedial	action	taken	as	necessary.	
Validated laboratory testing methods are needed to 
measure the contents (e.g. humectants and nicotine) 
and emissions (e.g. nicotine and carbon monoxide) of 
tobacco products for regulatory purposes and the 
cost	of	routine	compliance	testing,	as	well	as	verifica-
tion of industry data can be charged to tobacco man-
ufacturers.6	as	a	first	step,	countries	can	monitor	and	
build	intelligence	on	the	products	on	their	markets.	
Why is it important for these methods 
to be developed independently of the 
tobacco industry?
As tobacco products are manufactured and intri-
cately designed by the tobacco industry, their involve-
ment in developing methods to test these products 
would	be	a	clear	conflict	of	interest.	This	is	even	more	
crucial given that the tobacco industry has a long 
history	of	misleading	the	public	and	working	against	
well-intentioned tobacco-control policies.7 Examples 
include the use of ventilation holes in cigarettes to 
manipulate the emissions of tobacco products and 
promote so-called light and mild tobacco products 
as an alternative to quitting, while being fully aware 
that testing of these products, using International 
Organization	for	Standardisation	(ISO)	methods,	
will result in misleadingly low levels of the measured 
compounds. Therefore, tobacco industry activities, 
no matter how they are “dressed up”, should always 
be monitored with caution and scepticism and regula-
tory test methods should be developed and validated 
independently of the tobacco industry.
  
are	ISO	tobacco	testing	methods	independent?	
The industry exerts considerable influence on 
the	adopted	ISO	testing	methods	for	tobacco	and	
tobacco	products,	as	they	make	up	by	far	the	largest	
percentage of national and international technical 
committees.	This	led	to	WHO	establishing	an	alter-
native	global	network	of	independent	laboratories,	
the	WHO	Tobacco	Laboratory	Network	(TobLabNet),	
to develop the methods for testing these products 
rather than adopting those developed under indus-
try control and manipulation. Consequently, this will 
ensure the generation of independent and reliable 
information on tobacco products for regulatory 
purposes, thus building capacity for tobacco prod-
uct regulation and strengthening implementation of 
relevant provisions.
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More information on TobLabNet and its 
activities? 
TobLabNet	is	a	WHO	technical	advisory	body,	com-
prised of independent scientists with expertise in the 
fields	of	product	regulation	and	laboratory	analysis	
of tobacco contents, emissions and design features. 
It	was	established	in	2005	and	has	members	from	
the	six	regions	of	WHO.	TobLabNet	develops	and	
validates methods to test the contents and emis-
sions	of	tobacco	products,	supports	WHO	in	building	
testing	capacity	in	WHO	member	States,	and	runs	
training	workshops	in	countries	under	the	leader-
ship	of	WHO.	TobLabNet	works	in	unison	with	WHO	
Tobreg,	which	provides	scientifically	sound	and	evi-
dence-based recommendations to Member States 
through	the	WHO	Director-General	on	tobacco	
product regulation.
Find	more	 detailed	 information	 on	 the	 role	 of	
TobLabNet, how to become a member, how to 
request method development and/or assistance, etc. 
here.	Find	more	on	how	to	build	laboratory	testing	
capacities here. 
What	are	WHO	TobLabNet	methods	and	
how are they developed?
WHO	TobLabNet	methods8 are laboratory testing 
methods for tobacco and related products devel-
oped	by	part	of	WHO’s	global	technical	network	
on tobacco-product regulation. This group is made 
up of members from government, academic and 
other independent laboratories. TobLabNet meth-
ods are developed and validated independently 
of the tobacco industry, with no tobacco industry 
representative present at any of the meetings, nor 
involved in the development and validation of the 
methods	(unlike	ISO	committees	for	example).	These	
independent methods are recommended for use 
by regulators to test the contents and emissions of 
tobacco	products.	For	example,	TobLabNet	validated	
an	intense	smoking	protocol	for	generating	emissions	
from	cigarettes.	The	WHO	Study	Group	on	Tobacco	
Product	regulation	(Tobreg),	another	technical	advi-
sory	group	of	WHO	on	tobacco	product	regulation,	
recommends	the	use	of	an	intense	smoking	regime,	
rather	than	the	US	Federal	Trade	commission	(FTc)/
International	Organization	for	Standardisation	(ISO)	
testing regime.2 
What	is	the	difference	between	the	ISO	
and the intense regime?
The	ISO	regime	is	less	intense	than	human	smoking	
behaviour, especially in the case of cigarettes with a 
high	degree	of	filter	ventilation.	as	the	main	addictive	
component	in	cigarette	smoke	is	nicotine,	and	smok-
ers need a certain amount of nicotine to maintain 
their	addiction,	they	adapt	their	smoking	behaviour	
to	the	nicotine	levels	present	in	smoke.	One	of	the	
main factors determining nicotine levels are ventila-
tion	holes	in	the	cigarette	filter	that	dilute	smoke.	In	
response,	smokers	(partly)	close	the	ventilation	holes	
with	their	fingers	and	lips,	and	smoke	more	intensely.	
The	ventilation	holes	remain	open	in	the	ISO	regime,	
but are closed in the intense regime. Additionally, the 
intense regime uses larger, longer and deeper puffs. 
What are priority contents and emissions 
of tobacco products and which methods 
are available?
The priority contents and emissions identified by 
WHO9 are important targets for product regula-
tion. There are thousands of compounds in tobacco 
products	and	their	emissions,	of	which	the	39	most	
toxic compounds have been prioritised for testing by 
WHO-selected	independent	scientists.	The	WHO	
FcTc	conference	of	the	Parties	(cOP)	requested	
TobLabNet to develop testing methods for 12 of 
these compounds, which were further prioritised 
and considered the most important for monitoring.10 
Nine	of	these	are	the	toxicants	in	cigarette	smoke	
recommended for mandated lowering by TobReg 
(acetaldehyde,	acrolein,	Formaldehyde,	Benzene,	
1,3-Butadiene,	carbon	monoxide,	Benzo[a]pyrene,	
NNK, NNN),2 and the other three are priority con-
tents in tobacco, namely nicotine, humectants and 
ammonia.3,9 These methods are available to regula-
tors and other interested parties.11 As many coun-
tries	still	use	the	ISO	method	for	regulatory	pur-
poses and the principles of some of these methods 
guided the development and validation of TobLabNet 
methods,	ISO	methods	are	referenced	in	some	of	
the	TobLabNet	methods.	This	does	NOT	mean	that	
the industry had any involvement in developing the 
methods or interfered with the methods in any way. 
The reason is that TobLabNet methods are also vali-
dated	for	the	very	low	emission	levels	from	open	filter	
holes,	as	with	those	achieved	by	the	ISO	method.
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What is next for TobLabNet?
TobLabNet	continues	its	work	on	developing	and	val-
idating methods for measuring other compounds on 
the	priority	list	to	make	a	wider	range	of	methods	
available to countries. It also continues validating 
methods for analysis of contents and emissions of 
other tobacco and related products, such as elec-
tronic nicotine delivery systems (ENDS) including 
e-cigarettes,	heated	tobacco	products,	smokeless	
tobacco, waterpipe tobacco products and other 
tobacco	products.	TobLabNet’s	continuing	initia-
tives include efforts on building country capacity to 
implement validated methods. E-learning tools are 
being developed for training purposes on the vari-
ous	methods.	Further,	WHO	continues	to	work	with	
Member States and leverages the diverse expertise 
in TobLabNet and TobReg to build tobacco-product 
regulation capacity around the world. 
Information included in this publication was gathered with the 
support of funding from the Government of the Netherlands and 
collaboration	with	the	Netherlands	National	Institute	for	Public	
Health	and	the	Environment	(rIVm)	.
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